QMS Medical Allied Services reported mixed results for Q3FY26, with revenue at ₹37.3 Cr (-15% YoY) and PAT at ₹3.2 Cr. However, 9MFY26 revenue jumped 15% YoY to ₹128.5 Cr, showing strong overall growth, though PAT saw a slight dip to ₹9.9 Cr (EPS ₹4.59 vs ₹4.90 YoY). Products fueled 72% of 9MFY26 revenue, with services contributing 28%.
The company is strategically focused on expanding its high-growth Patient Support Programs (PSPs) and scaling healthcare camps into new therapeutic areas. Integration of Saarathi Healthcare and the expansion of its proprietary Q-Devices brand are key drivers. QMS conducted 24,142 B2B health camps in 9MFY26 and is leveraging the e-Grameen portal for rural access.
Management is confident in sustaining growth through strategic partnerships and scaling its digital health ecosystem, aiming for long-term value creation.